Australia-based SiteMinder benefited from being an early mover in the global hotel software space. It has joined a select group of local B2B players endowed with international scale and strong cashflow
Paul Wilson, co-founder of Bailador Technology Investments, believes hotel software specialist SiteMinder is poised to take its place among Australia’s B2B elite, alongside WiseTech Global, Altium, Atlassian,...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.